The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease.

ALT AST Berberis Integerrima Cholesterol NAFLD Total antioxidant capacity Triglyceride

Journal

Saudi journal of biological sciences
ISSN: 1319-562X
Titre abrégé: Saudi J Biol Sci
Pays: Saudi Arabia
ID NLM: 101543796

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 07 11 2019
revised: 03 03 2020
accepted: 03 04 2020
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 4 8 2020
Statut: ppublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) is one of the hepatic disorders which is characterized by increasing fat deposits in the liver. This disorder may lead to elevation the activity of liver enzymes and is associated with obesity, dyslipidemia, hypertension, and type II diabetes. The aim of present study was to investigate the effect of The present clinical trial was performed on 42 NAFLD patients who were randomly divided into two groups. The case group received a capsule (750 mg) containing hydro-alcoholic extract of Comparison rate of different parameters in case group before and after treatment demonstrated that BMI, cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal parameters such as aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase were significantly decreased while HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly elevated. The comparison of the mean parameters difference in two groups indicated that cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal factors were significantly decreased, however HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly increased in case group compared to control group. The study findings revealed that the

Sections du résumé

BACKGROUND BACKGROUND
Non-alcoholic fatty liver disease (NAFLD) is one of the hepatic disorders which is characterized by increasing fat deposits in the liver. This disorder may lead to elevation the activity of liver enzymes and is associated with obesity, dyslipidemia, hypertension, and type II diabetes. The aim of present study was to investigate the effect of
METHODS METHODS
The present clinical trial was performed on 42 NAFLD patients who were randomly divided into two groups. The case group received a capsule (750 mg) containing hydro-alcoholic extract of
RESULTS RESULTS
Comparison rate of different parameters in case group before and after treatment demonstrated that BMI, cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal parameters such as aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase were significantly decreased while HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly elevated. The comparison of the mean parameters difference in two groups indicated that cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal factors were significantly decreased, however HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly increased in case group compared to control group.
CONCLUSION CONCLUSIONS
The study findings revealed that the

Identifiants

pubmed: 32742180
doi: 10.1016/j.sjbs.2020.04.037
pii: S1319-562X(20)30159-5
pmc: PMC7384360
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2031-2037

Informations de copyright

© 2020 Published by Elsevier B.V. on behalf of King Saud University.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

World J Gastroenterol. 2014 Oct 21;20(39):14205-18
pubmed: 25339807
BMC Med Genet. 2016 Sep 05;17(1):63
pubmed: 27596100
Iran J Pharm Res. 2014 Fall;13(4):1313-8
pubmed: 25587320
Am J Clin Nutr. 2016 Feb;103(2):422-34
pubmed: 26791191
World J Gastroenterol. 2015 Dec 14;21(46):12989-95
pubmed: 26675364
J Lipid Res. 2006 Jun;47(6):1281-8
pubmed: 16508037
J Ethnopharmacol. 2016 Aug 22;190:387-95
pubmed: 27426508
Int J Reprod Biomed (Yazd). 2016 Feb;14(2):133-40
pubmed: 27200428
Medicine (Baltimore). 2016 Feb;95(5):e2630
pubmed: 26844476
Free Radic Biol Med. 2012 Jan 1;52(1):59-69
pubmed: 22064361
Hepat Mon. 2015 Feb 05;15(2):e25067
pubmed: 25788958
World J Gastroenterol. 2019 Jan 14;25(2):163-177
pubmed: 30670907
J Complement Integr Med. 2017 Mar 1;14(1):
pubmed: 28195545
World J Gastroenterol. 2017 Sep 28;23(36):6549-6570
pubmed: 29085205
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
J Zhejiang Univ Sci B. 2016 Jun;17(6):437-46
pubmed: 27256677
J Acupunct Meridian Stud. 2013 Feb;6(1):12-7
pubmed: 23433050
Phytother Res. 2012 Sep;26(9):1381-4
pubmed: 22308054
Iran J Basic Med Sci. 2017 May;20(5):552-556
pubmed: 28656090
Dig Dis Sci. 2010 Mar;55(3):560-78
pubmed: 20101463
Epilepsy Behav. 2010 Jul;18(3):207-10
pubmed: 20638957

Auteurs

Mehdi Afsharinasab (M)

Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Molecular Medicine Research Center, Institute of Basic Medical Sciences Research, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Maryam Mohammad-Sadeghipour (M)

Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Molecular Medicine Research Center, Institute of Basic Medical Sciences Research, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Department of Clinical Biochemistry, Afzalipoor Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Mohammad Reza Hajizadeh (M)

Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Molecular Medicine Research Center, Institute of Basic Medical Sciences Research, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Alireza Khoshdel (A)

Department of Clinical Biochemistry, Faculty of Medicine, and Pistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Vahid Mirzaiey (V)

Department of Internal Medicine, School of Medicine, and Physiology-Pharmacology Research Center, Ali Ibn Abitaleb Educational and Tretment Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Mehdi Mahmoodi (M)

Department of Clinical Biochemistry, Afzalipoor Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Classifications MeSH